Mathias Frederiksen
InvestorPrincipal at Novartis Venture Fund
Basel, Switzerland
Writes $5M – $10M checks · typically $7.5M
Find your path to Mathias
699 people in our graph share verified history with Mathias — schools, employers, funds. One of them is your warm intro.
Paul KwanunlockedMathias: together at Stanford University (2002–2004)
×2Mathias: together at Imperial College London
×9Mathias: together at Stanford University
About
Mathias Frederiksen is a Principal at the Novartis Venture Fund, based in Basel. Before joining NVF, he was a group leader in Novartis R&D, where his work covered neuroscience-focused medicinal chemistry, chemical genomics, and target discovery, with a focus on epigenetic dysregulation in disease, and he served on the portfolio management and strategy team. He holds a BSc in Chemistry from Mount Allison University, a PhD in Chemistry from Imperial College London, and completed a postdoctorate at Stanford University.
Experience
- Novartis Venture FundPrincipalcurrent2023 — presentBasel, Switzerland
- Novartis Venture FundAssociate2022 — 2023Basel, Switzerland
- AravaxDirector Board of Directorscurrent2026 — present
- NRG TherapeuticsBoard Observercurrent2025 — presentStevenage, England, United Kingdom
- Averna TherapeuticsBoard Observercurrent2024 — presentBoston, Massachusetts, United States
- UZH Life Sciences FundInvestment Managercurrent2022 — presentZurich, Switzerland
- LoQus23 Therapeutics LtdBoard Observercurrent2022 — presentCambridge, England, United Kingdom
- FundaMental PharmaDirector Board of Directors2023 — 2025Heidelberg, Baden-Württemberg, Germany
- Para TherapeuticsBoard Observer2023 — 2025San Francisco Bay Area
- Novartis Institutes for BioMedical Research (NIBR)Associate Director and Group Leader Chomatin Chemical Biology2020 — 2022Basel Area, Switzerland
- Novartis Institutes for BioMedical Research (NIBR)Senior Investigator II2018 — 2020Basel Area, Switzerland
- Novartis Institutes for BioMedical Research (NIBR)Senior Investigator I2014 — 2018Basel Area, Switzerland
- Novartis Institutes for BioMedical Research (NIBR)Investigator III2010 — 2014
- Novartis Institutes for BioMedical Research (NIBR)Research Investigator II2007 — 2009
- Novartis Institutes for BioMedical Research (NIBR)Research Investigator I2005 — 2007
- Stanford UniversityPost-doctoral Research Investigator2003 — 2004
- Imperial College LondonPhD Candidate1998 — 2002
Skills & more
Start-up Ventures4Corporate Venture Capital5Company build3Venture CapitalVenture FinancingFinanceEpigenetics11Medicinal Chemistry80Drug Design68Organic Synthesis47Drug Discovery99Life Sciences20
+12 more
ProteomicsCell Based AssaysOrganic ChemistrySignal TransductionTarget IdentificationLifesciencesPharmaceutical IndustryLead ChangeAssay DevelopmentDrug DevelopmentCellGPCRsLanguages English · French · German · Norwegian
From Mathias's professional profile.
Investments
Investor
FundaMental Pharma
Per curated public sources.
Colleagues at Novartis Venture Fund
Adam Cotton
Principal at the Novartis Venture Fund
Anís
Head of Scoping, Pharma at Deep Science Ventures
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Campbell Murray
Advisor
Christoph Meier
Investor at Novartis Venture Fund
Frequently asked questions
- Who is Mathias Frederiksen?
- Mathias Frederiksen is a Principal at the Novartis Venture Fund, based in Basel. Before joining NVF, he was a group leader in Novartis R&D, where his work covered neuroscience-focused medicinal chemistry, chemical genomics, and target discovery, with a focus on epigenetic dysregulation in disease, and he served on the portfolio management and strategy team. He holds a BSc in Chemistry from Mount Allison University, a PhD in Chemistry from Imperial College London, and completed a postdoctorate at Stanford University.
- Where does Mathias Frederiksen work?
- Mathias Frederiksen is Principal at Novartis Venture Fund.
- What check size does Mathias Frederiksen write?
- Mathias Frederiksen typically writes checks of $5M – $10M.
- What companies has Mathias Frederiksen invested in?
- Investments tracked here include FundaMental Pharma.
- Where did Mathias Frederiksen go to school?
- Mathias Frederiksen studied at Stanford University (Post-Doc, Chemistry); Imperial College London (PhD, Synthetic Organic Chemistry); Mount Allison University (B.Sc, Chemistry).
Same school
Also attended Stanford University2,000
Peter ThielCo-founder & Partner at Founders FundDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia CapitalJim BreyerFounder & CEO of Breyer CapitalMike Maples JrCo-founding Partner at Floodgate
+ 1,994 more
Also attended Imperial College London824
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at MedicxiBen PerryInvestor at Medicxi
+ 818 more
Also attended Mount Allison University24
Anamitra DebSenior Vice President, Programs and Policy at Omidyar NetworkAnnie TheriaultManaging Partner at Cross-Border Impact VenturesSarah YoungFounding and Managing Partner at Sandpiper VenturesBarbara M. CampbellRegional Director, NPC-Atlantic Canada at Natural Products CanadaBen WinnVP Communities & Content at FirstMarkAnnie ThériaultManaging Partner at Cross-Border Impact Ventures
+ 18 more
Also attended UWC Atlantic College19
Noah FreyFinance Analyst at Emerald Technology Ventures AgFaris AyoubPartner, Helios Sports and Entertainment Group at Helios Digital VenturesHaakon OverliGeneral Partner at Dawn Capital LLPTomás Álvarez BelónInvestor at Innovation EndeavorsEllasaid WoodhouseInvestment Manager at Old College CapitalMatthias SchanzeGeneral Partner at Rethink Ventures
+ 13 more
Shared employers
Also worked at Novartis Venture Fund332
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 326 more
